BMPR-IB reduces the malignancy of glioblastoma cells by upregulation of p21 and p27Kip1

Cancer Science & Therapy

ISSN: 1948-5956

Open Access

BMPR-IB reduces the malignancy of glioblastoma cells by upregulation of p21 and p27Kip1

3rd World Congress on Cancer Science & Therapy

October 21-23, 2013 DoubleTree by Hilton Hotel San Francisco Airport, CA, USA

Shuang Liu, Feng Yin, Jianning Zhang, Wenhong Fan and Ming Fan

Accepted Abstracts: J Cancer Sci Ther

Abstract :

In the present study, we detected decreased expression of phospho-Smad1/5/8 and its upstream signaling molecule, bone morphogenetic protein receptor IB subunit (BMPR-IB), in certain glioblastoma cell lines compared to normal astrocytes. Forced BMPR-IB expression in malignant human glioma cells, which exhibit lower expression of BMPR-IB, induced the phosphorylation and nuclear localization of smad1/5/8 and arrested the cell cycle in G1. Additionally, colony formation analysis and immunofluorescence showed that BMPR-IB overexpression could suppress anchorage-independent growth and promote differentiation of theses glioblastoma cells. We also observed significant accumulation of p21 and p27kip1 proteins in response to BMPR-IB overexpression, whereas the expression level of Skp2 protein decreased during this growth arrest and differentiation process. The results were consistent with real-time RT-PCR data. Furthermore, overexpression of BMPR-IB also inhibited the growth of subcutaneous and intracranial tumor xenografts and prolonged the survival of mice injected intracranially with BMPR-IB-overexpressing glioblastoma cells. Conversely, inhibition of BMPR-IB caused SF763 malignant glioma cells, a line known to exhibit high BMPR-IB expression that does not form tumors when used for xenografts, to show increased growth and regain tumorigenicity in a nude mouse model system, ultimately shortening the survival of these mice. Our results suggest that decreased expression of BMPR-IB in most human glioblastoma cells contributes to glioma tumorigenicity and that overexpression of BMPR-IB may induce growth arrest and differentiation of glioblastoma cells due to upregulation of p21 and p27kip1 in vitro and in vivo . BMPR-IB could represent a new potential therapeutic target for malignant human gliomas.

Biography :

Shuang Liu has studied molecular biology and molecular therapeutics of brain tumor and stem cells for 10+ years, during which time she has been in charge many research projects about glioma and cancer stem cells, including two Chinese National Science Foundation (No: 30873029 and No: 81172384). She authored more than 20 peer-reviewed reports. Dr. Shuang is a member of the Chinese Neuroscience Society, and has served on the editorial boards for Chinese Journal of Integrated Traditional and Western Medicine for about 10 years.


tempobet giriş

tempobet giriş


tipobet yeni giriş adresi tipobet e yeni giriş tipobet güncel giriş adresi imajbet giriş adresi

mobilbahis giriş

arrow_upward arrow_upward